AC Immune SA | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (16)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Article By: Benzinga
Saturday, September 26, 2020 3:55 PM EDT
Biotech stocks reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson kickstarting a Phase 3 trial of its coronavirus vaccine candidate.
In this article: JNJ, CAPR, XNCR, MESO, ACIU, SBPH, VCNX, AQST, MGTX, ETON
Read
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Article By: Benzinga
Sunday, July 26, 2020 4:29 PM EDT
Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the week.
In this article: RARE, NVAX, BIIB, ESALY, ATRC, MRNA, GWPH, GNCA, ACIU, ALEC, TCRR
Read
4 Small Drug Stocks In Focus Ahead Of World Alzheimer's Day
Article By: Zacks Investment Research
Friday, September 20, 2019 6:33 PM EDT
Given the unmet need in the AD space and the risks associated with the disease, favorable development of any of these candidates will be a great boost to the concerned companies.
In this article: ITCI, VTVT, ALEC, SAVA Also: ACIU
Read
Roche, Prothena Off To PhII With Their Disease-Modifying Parkinson’s Drug
Article By: Lorimer Wilson
Monday, April 3, 2017 5:41 AM EDT
Prothena turned up at the big Alzheimer’s/Parkinson’s conference in Vienna this weekend and presented early-stage data showing how its Roche-partnered drug PRX002/RG7935 can flush out toxic clusters of alpha-synuclein in Parkinson’s patients.
In this article: PRTA Also: PRAN, ACIU
Read
All Posts

Latest Tweets for $ACIU

No tweets yet!

PARTNER HEADLINES